documents: FDA-2019-E-3278-0008

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-E-3278-0008 FDA FDA-2019-E-3278 Determination of Regulatory Review Period for Purposes of Patent Extension; DELSTRIGO—New Drug Application 210807 Notice Determinations 2023-08-04T04:00:00Z 2023 8 2023-08-04T04:00:00Z 2023-10-04T03:59:59Z 2023-08-04T15:49:29Z 2023-16606 0 0 0900006485dc5b38

Links from other tables